| dc.creator | Budenz | |
| dc.creator | DL; Feuer | |
| dc.creator | WJ; Barton | |
| dc.creator | K; Schiffman | |
| dc.creator | J; Costa | |
| dc.creator | VP; Godfrey | |
| dc.creator | DG; Buys | |
| dc.creator | YM | |
| dc.date | 2016 | |
| dc.date | 2016-12-06T18:29:16Z | |
| dc.date | 2016-12-06T18:29:16Z | |
| dc.date.accessioned | 2018-03-29T02:01:50Z | |
| dc.date.available | 2018-03-29T02:01:50Z | |
| dc.identifier | 1879-1891 | |
| dc.identifier | American Journal Of Ophthalmology. ELSEVIER SCIENCE INC, n. 163, p. 75 - 82. | |
| dc.identifier | 0002-9394 | |
| dc.identifier | WOS:000371447500012 | |
| dc.identifier | 10.1016/j.ajo.2015.11.023 | |
| dc.identifier | http://www-sciencedirect-com.ez88.periodicos.capes.gov.br/science/article/pii/S0002939415007114 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/319746 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1310512 | |
| dc.description | PURPOSE: To compare the late complications in the Ahmed Baerveldt Comparison Study during 5 years of follow-up. DESIGN: Multicenter, prospective randomized clinical trial. METHODS: SETTING: Sixteen international clinical centers. STUDY POPULATION: Two hundred seventy-six subjects aged 18.85 years with previous intraocular surgery or refractory glaucoma with intraocular pressure of > 18 mm Hg. INTERVENTIONS: Ahmed Glaucoma Valve FP7 or Baerveldt Glaucoma Implant BG 101-350. MAIN OUTCOME MEASURES: Late postoperative complications (beyond 3 months), reoperations for complications, and decreased vision from complications. RESULTS: Late complications developed in 56 subjects (46.8 +/- 4.8 5-year cumulative % SE) in the Ahmed Glaucoma Valve group and 67 (56.3 +/- 4.7 5-year cumulative % +/- SE) in the Baerveldt Glaucoma Implant group (P=.082). The cumulative rates of serious complications were 15.9% and 24.7% in the Ahmed Glaucoma Valve and Baerveldt Glaucoma Implant groups, respectively (P=.034), although this was largely driven by subjects who had tube occlusions in. the 2 groups (0.8% in the Ahmed Glaucoma Valve group and 5.7% in the Baerveldt Glaucoma Implant group, P=.037). Both groups had a relatively high incidence of persistent diplopia (12%) and corneal edema (20%), although half of the corneal edema cases were likely due to pre-existing causes other than the aqueous shunt. The incidence of tube erosion was 1% and 3% in the Ahmed Glaucoma Valve and Baerveldt Glaucoma Implant groups, respectively (P=.04). CONCLUSIONS: Long-term rates of vision-threatening complications and complications resulting in reoperation were higher in the Baerveldt Glaucoma Implant than in the Ahmed Glaucoma Valve group over 5 years of follow-up. (C) 2016 by Elsevier Inc. All rights reserved. | |
| dc.description | 163 | |
| dc.description | | |
| dc.description | 75 | |
| dc.description | 82 | |
| dc.description | NIH [P30 EY014801] | |
| dc.description | RESEARCH TO PREVENT BLINDness, New York, New York, USA (University of North Carolina) | |
| dc.description | RESEARCH TO PREVENT BLINDness, New York, New York, USA (University of Miami) | |
| dc.description | New World Medical, Inc | |
| dc.description | Rancho Cucamonga, California, USA (University of Miami) | |
| dc.description | | |
| dc.description | | |
| dc.description | | |
| dc.language | English | |
| dc.publisher | ELSEVIER SCIENCE INC | |
| dc.publisher | NEW YORK | |
| dc.relation | American Journal Of Ophthalmology | |
| dc.rights | fechado | |
| dc.source | WOS | |
| dc.title | Postoperative Complications In The Ahmed Baerveldt Comparison Study During Five Years Of Follow-up | |
| dc.type | Artículos de revistas | |
